These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24132737)

  • 1. A matched case-control study of IBD-associated colorectal cancer: IBD portends worse outcome.
    Hrabe JE; Byrn JC; Button AM; Zamba GK; Kapadia MR; Mezhir JJ
    J Surg Oncol; 2014 Feb; 109(2):117-21. PubMed ID: 24132737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer prognosis among patients with inflammatory bowel disease.
    Delaunoit T; Limburg PJ; Goldberg RM; Lymp JF; Loftus EV
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):335-42. PubMed ID: 16527697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features, treatment, and survival of patients with colorectal cancer with or without inflammatory bowel disease.
    Ali RA; Dooley C; Comber H; Newell J; Egan LJ
    Clin Gastroenterol Hepatol; 2011 Jul; 9(7):584-9.e1-2. PubMed ID: 21565283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes from IBD-associated and non-IBD-associated colorectal cancer: a Surveillance Epidemiology and End Results Medicare study.
    Gearhart SL; Nathan H; Pawlik TM; Wick E; Efron J; Shore AD
    Dis Colon Rectum; 2012 Mar; 55(3):270-7. PubMed ID: 22469793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel Disease.
    Axelrad J; Kriplani A; Ozbek U; Harpaz N; Colombel JF; Itzkowitz S; Holcombe RF; Ang C
    Clin Colorectal Cancer; 2017 Sep; 16(3):e205-e210. PubMed ID: 27742264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
    Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study.
    Baars JE; Looman CW; Steyerberg EW; Beukers R; Tan AC; Weusten BL; Kuipers EJ; van der Woude CJ
    Am J Gastroenterol; 2011 Feb; 106(2):319-28. PubMed ID: 21045815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease.
    Derikx LA; Kievit W; Drenth JP; de Jong DJ; Ponsioen CY; Oldenburg B; van der Meulen-de Jong AE; Dijkstra G; Grubben MJ; van Laarhoven CJ; Nagtegaal ID; Hoentjen F;
    Gastroenterology; 2014 Jan; 146(1):119-28.e1. PubMed ID: 24076060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors of colorectal cancer in inflammatory bowel disease.
    Bansal P; Sonnenberg A
    Am J Gastroenterol; 1996 Jan; 91(1):44-8. PubMed ID: 8561142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncological outcomes of IBD-associated versus sporadic colorectal cancer in modern era: a matched case-control study.
    Thicoïpé A; Laharie D; Smith D; Chabrun E; Rullier A; Poullenot F; Rullier E; Denost Q
    Int J Colorectal Dis; 2018 Jul; 33(7):963-966. PubMed ID: 29675590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis of the clinicopathological characteristics and survival outcomes of inflammatory bowel disease associated colorectal cancer.
    Reynolds IS; O'Toole A; Deasy J; McNamara DA; Burke JP
    Int J Colorectal Dis; 2017 Apr; 32(4):443-451. PubMed ID: 28078433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.
    Jess T; Simonsen J; Jørgensen KT; Pedersen BV; Nielsen NM; Frisch M
    Gastroenterology; 2012 Aug; 143(2):375-81.e1; quiz e13-4. PubMed ID: 22522090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience.
    Kiran RP; Khoury W; Church JM; Lavery IC; Fazio VW; Remzi FH
    Ann Surg; 2010 Aug; 252(2):330-5. PubMed ID: 20622662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-Related Survival Differences in Patients With Inflammatory Bowel Disease-Associated Colorectal Cancer: A Population-Based Cohort Study.
    Bogach J; Pond G; Eskicioglu C; Seow H
    Inflamm Bowel Dis; 2019 Nov; 25(12):1957-1965. PubMed ID: 31066449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males.
    Söderlund S; Granath F; Broström O; Karlén P; Löfberg R; Ekbom A; Askling J
    Gastroenterology; 2010 May; 138(5):1697-703. PubMed ID: 20167217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.
    Bernstein CN; Nugent Z; Blanchard JF
    Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease severity does not affect the interval between IBD diagnosis and the development of CRC: results from two large, Dutch case series.
    Mooiweer E; Baars JE; Lutgens MW; Vleggaar F; van Oijen M; Siersema PD; Kuipers EJ; van der Woude CJ; Oldenburg B
    J Crohns Colitis; 2012 May; 6(4):435-40. PubMed ID: 22398065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of surveillance colonoscopy in medicare patients with inflammatory bowel disease prior to colorectal cancer diagnosis.
    Wang YR; Cangemi JR; Loftus EV; Picco MF
    Digestion; 2014; 90(1):58-62. PubMed ID: 25196002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?
    Bernstein CN; Blanchard JF; Metge C; Yogendran M
    Am J Gastroenterol; 2003 Dec; 98(12):2784-8. PubMed ID: 14687833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.